The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering the United States.

St. David's North Austin Medical Center is the first in Central Texas to use FDA-approved fluorescent imaging to improve lung cancer surgery.

Sentara Health’s chief medical officer says new guidance from the Virginia Department of Health is helping clear up confusion about access to the latest COVID-19 vaccine.

Ascension became the first provider in Wisconsin to administer Kisunla, a new FDA-approved drug for Alzheimer’s, which is covered by insurance.

The FDA approved Johnson & Johnson's Inlexzo, offering a new bladder cancer treatment option with high response rates for patients, avoiding surgery.

Known as Vizz, the once-daily eye drops treat age-related blurry near vision — also known as presbyopia — for up to 10 hours at a time.

As North Carolina grapples with new hurdles in COVID-19 vaccine distribution, officials await crucial ACIP guidelines. Officials say the decision could impact vaccine availability and raises concerns among health officials and residents about future access and rollout strategies.

Feeling like you're sweating more than usual? Chico Dermatologist Dr. Kafele Hodari offers an FDA-approved solution with Botox to tackle severe hyperhidrosis, a condition affecting millions in the U.S.

Bovine respiratory disease (BRD) is a common — and complex — health issue that is estimated to cost the U.S. dairy and beef industries around $1 billion annually, according to a Texas A&M University article.

Ocaliva, approved for primary biliary cholangitis, faced FDA warnings and restrictions after postmarket data showed higher risks of liver transplant and death among treated patients.